Position in VRTX
as of Dec 31, 2025
· filed Jan 14, 2026
Position Value
$87,478
-$8,844 QoQ
Shares Held
193
-21.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Dec 31, 2025ORG Partners LLC holds $451,319 across 39 Biotechnology names. VRTX ranks #2 (19.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
657 | $114,334 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
193 | $87,478 | |
| 3 | LCTX |
Lineage Cell Therapeutics, Inc.
|
34,600 | $57,782 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
69 | $53,245 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
73 | $29,020 | |
| 6 | IMNM |
Immunome Inc.
|
880 | $18,900 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
136 | $10,400 | |
| 8 | ONC |
BeOne Medicines Ltd.
|
33 | $10,024 |
All Filings in VRTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $87,478 | 193 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $96,322 | 246 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $111,286 | 250 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $103,242 | 213 | Shares | Sole | 2025-04-21 | |
| 2024-12-31 | $41,056 | 102 | Shares | Sole | 2025-01-10 | |
| 2024-09-30 | $22,785 | 49 | Shares | Sole | 2024-10-11 | |
| 2024-06-30 | $24,353 | 52 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,344 | 8 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $6,101 | 15 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $19,797 | 57 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $21,461 | 61 | Shares | Sole | 2023-07-25 | |
| No filing history on record for this holder in this stock. | ||||||